XML 30 R20.htm IDEA: XBRL DOCUMENT v3.19.1
Summary Of Business And Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2016
Accounting Policies [Abstract]  
Reconciliation Of Items Measured At Fair Value On Recurring Basis
The following table provides a reconciliation between the beginning and ending balances of items measured at fair value on a recurring basis that used significant unobservable inputs (Level 3) (in thousands):

 
Contingent
Consideration
BCI
Balance at December 31, 2015
$
739

Gains or losses included in earnings:
 
Losses on revaluation of contingent consideration
11

Payment of contingent consideration
(750
)
Balance at June 30, 2016
$

Schedule of Error Corrections and Prior Period Adjustments [Table Text Block]
The following table presents the Company’s condensed consolidated statements of income (loss) as previously reported, restatement adjustments and the condensed consolidated statements of income (loss) as restated for the three and six months ended June 30, 2016 (in thousands, except per share amounts):




Condensed Consolidated Statements of Income (Loss)(Unaudited)
 
 
 
 
 
 
 
 
(In thousands, except per share amounts)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Three Months Ended June 30, 2016
 
Six Months Ended June 30, 2016
 
As Previously Reported
 
 Adjustments
 
As Restated
 
As Previously Reported
 
 Adjustments
 
As Restated
Revenues:
 
 
 
 
 
 
 
 
 
 
 
Healthcare
$
48,070

 
$
(2,455
)
(a)
$
45,615

 
$
98,440

 
$
(2,455
)
(a)
$
95,985

Commuter
17,383

 
83

(b)
17,466

 
34,759

 
83

(b)
34,842

COBRA
17,879

 
(672
)
(c)
17,207

 
33,285

 
(672
)
(c)
32,613

Other
4,393

 
(18
)
(b)
4,375

 
8,243

 
(18
)
(b)
8,225

Total revenues
87,725

 
(3,062
)
 
84,663

 
174,727

 
(3,062
)
 
171,665

Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of revenues (excluding amortization of internal use software)
28,411

 
18

(d)
28,429

 
59,671

 
18

(d)
59,689

Technology and development 
11,157

 
(321
)
(e)
10,836

 
20,988

 
(321
)
(e)
20,667

Sales and marketing 
14,385

 
(249
)
(f)
14,136

 
28,305

 
(249
)
(f)
28,056

General and administrative 
17,130

 
(1,662
)
(g)
15,468

 
31,745

 
(1,662
)
(g)
30,083

Amortization, impairment and change in contingent consideration
11,695

 
3,669

(h)
15,364

 
19,140

 
3,669

(h)
22,809

Employee termination and other charges
313

 

 
313

 
313

 

 
313

Total operating expenses
83,091

 
1,455

 
84,546

 
160,162

 
1,455

 
161,617

Income (loss) from operations
4,634

 
(4,517
)
 
117

 
14,565

 
(4,517
)
 
10,048

Other income (expense):
 
 
 
 
 
 
 
 
 
 
 
Interest income
97

 

 
97

 
183

 

 
183

Interest expense
(409
)
 
(413
)
(i)
(822
)
 
(814
)
 
(413
)
(i)
(1,227
)
Other income (expense)
6

 
(132
)
(j)
(126
)
 
2

 
(132
)
(j)
(130
)
Income before income (loss) taxes
4,328

 
(5,062
)
 
(734
)
 
13,936

 
(5,062
)
 
8,874

Income tax (provision) benefit
(1,475
)
 
2,089

 
614

 
(5,287
)
 
2,089

 
(3,198
)
Net income (loss)
$
2,853

 
$
(2,973
)
 
$
(120
)
 
$
8,649

 
$
(2,973
)
 
$
5,676

Net income (loss) per share:
 
 
 
 
 
 
 
 
 
 
 
Basic
$
0.08

 
$
(0.08
)
 
$

 
$
0.24

 
$
(0.08
)
 
$
0.16

Diluted
$
0.08

 
$
(0.08
)
 
$

 
$
0.23

 
$
(0.08
)
 
$
0.15

Shares used in computing net income (loss) per share:
 
 
 
 
 
 
 
 
 
 
 
Basic
36,361

 


 
36,361

 
36,139

 


 
36,139

Diluted
37,195

 


 
36,361

 
36,862

 


 
36,862


(a)
Revenue adjustment of $2.5 million was primarily due to (i) a $1.1 million reversal of OPM revenue as discussed above, (ii) $0.7 million reversal of revenue as a result of the correction of billing errors and the recognition of invoices and related invoice adjustments in the proper reporting period, and (iii) a $0.6 million reversal of revenue due to the netting of healthcare revenue against certain cost of revenue expenses.
(b)
Revenue adjustment related to the correction of billing errors and the recognition of invoices and credit memos in the correct reporting periods.
(c)
Revenue adjustment of $0.7 million related to the correction of billing errors and the recognition of credit memos in the correct reporting periods.
(d)
Adjustment of $0.6 million primarily related to the reserve of potentially uncollectible customer obligations for pass through employee participant reimbursement, offset by a $0.6 million reversal related to the netting of healthcare revenue against certain cost of revenue expenses.
(e)
Reduction primarily related to the over-accrual of platform technology related expenses.
(f)
Reduction related primarily to the over-accrual of commission expenses.
(g)
Adjustments related to (i) a $1.2 million reduction in stock-based compensation expense as a result of reduced target attainment percentages expected for performance-based restricted stock units (see above for details), (ii) the reversal of $0.2 million related to the re-valuation of the allowance for bad debt and (iii) a $0.2 million expense reduction related to the re-valuation and write-off of customer obligations.
(h)
Adjustment related to the impairment charge of Internally Developed Software ("IDS") in connection with a joint development agreement with a customer as discussed above in the Internally Developed Software Impairment section.
(i)
Adjustment related to accrued interest expense on unreported employee participant and employer clients unclaimed property.
(j)
Adjustment related to accrued penalties on unreported employee participant and employer clients unclaimed property.
The following table presents the condensed consolidated balance sheet as previously reported, restatement adjustments and the condensed consolidated balance sheet as restated at June 30, 2016 (in thousands):
Condensed Consolidated Balance Sheets (Unaudited)
 
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
June 30, 2016
 
 
As Previously Reported
 
 Adjustments
 
As Restated
Assets
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
Cash and cash equivalents
 
$
568,993

 
$
(323
)
(a)
$
568,670

Restricted cash
 
332

 

 
332

Accounts receivable, net
 
93,979

 
(7,103
)
(b)
86,876

Prepaid expenses and other current assets
 
18,239

 
63

(c)
18,302

Total current assets
 
681,543

 
(7,363
)
 
674,180

Property and equipment, net
 
48,426

 
(3,123
)
(d)
45,303

Goodwill
 
157,109

 

 
157,109

Acquired intangible assets, net
 
90,769

 

 
90,769

Deferred tax assets
 
9,837

 

 
9,837

Other assets
 
4,275

 
(1
)
 
4,274

Total assets
 
$
991,959

 
$
(10,487
)
 
$
981,472

Liabilities and Stockholders' Equity
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
Accounts payable and accrued expenses
 
$
71,399

 
$
(275
)
(e)
$
71,124

Customer obligations
 
468,153

 
(2,015
)
(f)
466,138

Other current liabilities
 
1,589

 
242

(g)
1,831

Total current liabilities
 
541,141

 
(2,048
)
 
539,093

Long-term debt
 
79,064

 

 
79,064

Other non-current liabilities
 
10,152

 
(2,060
)
(h)
8,092

Total liabilities
 
630,357

 
(4,108
)
 
626,249

Stockholders' Equity:
 
 
 
 
 
 
Common stock
 
38

 

 
38

Additional paid-in capital
 
368,519

 
(3,406
)
(i)
365,113

Treasury stock at cost
 
(14,374
)
 

 
(14,374
)
Retained earnings
 
7,419

 
(2,973
)
 
4,446

Total stockholders' equity
 
361,602

 
(6,379
)
 
355,223

Total liabilities and stockholders' equity
 
$
991,959

 
$
(10,487
)
 
$
981,472


(a)
Adjustment due to the timing differences between the obligation payments from employer clients and the receipt of cash in the Company's bank accounts, which resulted in a reclassification from cash and cash equivalents to customer obligations.
(b)
Adjustment relates to (i) a $4.1 million reduction in accounts receivable from the restatement of OPM revenue as discussed above, of which $1.1 million relates to the reduction of revenue and $3.0 million relates to the reduction of short-term and long-term deferred revenue, (ii) a $1.8 million reduction from the reclassification of accounts receivable to customer obligations based on the correction of the timing of customer billing and payments, and (iii) a $1.2 million decrease due to accruals to correct the recording of invoices, credit memos and billing adjustments in the proper period.
(c)
Adjustment primarily to record other receivables for the anticipated collection of commission over-payments.
(d)
Adjustments relates to the impairment charge for IDS of $3.7 million, as discussed above, partially offset by $0.6 million of assets under capital lease obligations originally recognized incorrectly as operating leases.
(e)
Adjustment relates to a $0.7 million reduction in short-term deferred revenue as result of the OPM restatement discussed above and a $0.4 million reduction due to the over accrual of operating expenses, partially offset by a $0.5 million accrual related to interest and penalties for unreported employee participant and employer clients unclaimed property, and a $0.3 million accrual for a customer cash refund related to billing errors.
(f)
Adjustment relates to (i) a $1.8 million decrease due to the reclassification of customer obligations from accounts receivable based on the correction of the timing of employer client billings and payments, (ii) a $0.3 million decrease due to the timing differences between the obligation payments from employer clients and the receipt of cash in the Company's bank accounts, which resulted in a reclassification from cash and cash equivalents to customer obligations, (iii) a $0.6 million decrease related to the re-valuation and write-off of customer obligations, and (iv) an increase of $0.7 million to record a reserve for potentially uncollectible customer obligations for pass-through employee participant reimbursements.
(g)
Adjustment to record the current portion of capital lease obligations originally recognized incorrectly as operating leases.
(h)
Adjustment relates to the reduction of long-term deferred revenue of $2.4 million in connection with the Company's OPM restatement as noted above, partially offset by an increase of $0.3 million related to the long-term portion of capital lease obligations originally reported incorrectly as operating leases.
(i)
Adjustment relates to a tax provision reduction of $2.1 million for the six months ended June 30, 2016 due to the reduction in net income as a result of the misstatements and a reduction in stock compensation of $1.3 million as a result of reduced target attainment percentages expected for performance-based restricted stock units.


The following table presents the Company's condensed consolidated statement of cash flows as previously reported, restatement adjustments and the condensed consolidated statement of cash flows as restated for the six months ended June 30, 2016 (in thousands):
Condensed Consolidated Statement of Cash Flows (Unaudited)
 
 
 
 
(In thousands)
 
 
 
 
 
 
 
 
 
 
 
 
Six Months Ended June 30, 2016
 
As Previously Reported
 
 Adjustments
 
As Restated
Cash flows from operating activities:
 
 
 
 
 
Net income
$
8,649

 
$
(2,973
)
 
$
5,676

Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
 

Depreciation
3,813

 
78

 
3,891

Amortization, impairment and change in contingent consideration
19,042

 
3,835

 
22,877

Stock-based compensation expense
14,842

 
(1,318
)
 
13,524

Loss on disposal of fixed assets
199

 

 
199

Provision for doubtful accounts
996

 
(197
)
 
799

Deferred taxes

 

 

Excess tax benefit related to stock-based compensation arrangements
(5,287
)
 
2,088

 
(3,199
)
Changes in operating assets and liabilities:
 
 

 

Accounts receivable
(22,704
)
 
7,300

 
(15,404
)
Prepaid expenses and other current assets
302

 
(2,151
)
 
(1,849
)
Other assets
172

 

 
172

Accounts payable and accrued expenses
(1,848
)
 
(275
)
 
(2,123
)
Customer obligations
67,332

 
(2,015
)
 
65,317

Other liabilities
1,136

 
(2,331
)
 
(1,195
)
Net cash provided by operating activities
86,644

 
2,041

 
88,685

Cash flows from investing activities:
 
 
 
 
 
Purchases of property and equipment
(10,430
)
 

 
(10,430
)
Cash paid for acquisition of intangible assets
(14,259
)
 

 
(14,259
)
Net cash used in investing activities
(24,689
)
 

 
(24,689
)
Cash flows from financing activities:
 

 
 
 
 
Proceeds from exercise of common stock options
9,665

 

 
9,665

Proceeds from issuance of common stock under Employee Stock Purchase Plan
1,192

 

 
1,192

Payment of contingent consideration
(653
)
 
(97
)
 
(750
)
Payment for treasury stock acquired
(9,371
)
 

 
(9,371
)
Payment of capital lease obligations

 
(179
)
 
(179
)
Excess tax benefit related to stock-based compensation arrangements
5,287

 
(2,088
)
 
3,199

Net cash provided by financing activities
6,120

 
(2,364
)
 
3,756

Net increase in cash and cash equivalents
68,075

 
(323
)
 
67,752

Cash and cash equivalents at beginning of the year
500,918

 
 
 
500,918

Cash and cash equivalents at end of period
$
568,993

 
$
(323
)
 
$
568,670

Noncash financing and investing activities:
 
 
 
 
 
Property and equipment purchased under capital lease obligations
$

 
$
626

 
$
626

Performance-based restricted stock units compensation expense (in millions):
 
Three Months Ended June 30, 2016
 
Six Months Ended June 30, 2016
 
 
 
 
 
 
 
 
 
As Previously Reported
 Adjustments
As restated
 
As Previously Reported
 Adjustments
As restated
Stock-based compensation expense related to restricted stock units (in millions)
$
6.2

$
(1.3
)
$
4.9

 
$
10.0

$
(1.3
)
$
8.7

 
 
 
 
 
 
 
 
 
At June 30, 2016
 
 
 
 
 
As Previously Reported
 Adjustments
As restated
 
 
 
 
Total unrecorded stock-based compensation cost associated with restricted stock units (in millions)
$
37.5

$
(12.6
)
$
24.9

 
 
 
 



Total restatement adjustments for stock-based compensation expense (in thousands):
 
Three Months Ended June 30, 2016
 
Six Months Ended June 30, 2016
 
 
 
 
 
 
 
 
 
As Previously Reported
 Adjustments
As restated
 
As Previously Reported
 Adjustments
As restated
Cost of revenues
$
1,818

$

$
1,818

 
$
2,968

$

$
2,968

Technology and development
659

(38
)
621

 
1,144

(38
)
1,106

Sales and marketing
791

(53
)
738

 
1,498

(52
)
1,446

General and administrative
5,583

(1,227
)
4,356

 
9,232

(1,228
)
8,004

Total
$
8,851

$
(1,318
)
$
7,533

 
$
14,842

$
(1,318
)
$
13,524